Nuclein's DASH® SARS-CoV-2 & Flu A/B Test Achieves FDA Clearance for Rapid Diagnosis Nuclein's DASH® SARS-CoV-2 & Flu A/B Test has obtained FDA 510(k) clearance and CLIA waiver, revolutionizing rapid diagnostic testing.

Nuclein's DASH® SARS-CoV-2 & Flu A/B Test Achieves FDA Clearance for Rapid Diagnosis #USA #Austin #Nuclein #CovarsaDx #DASH_Test

Nuclein Achieves FDA Clearance for Rapid SARS-CoV-2 and Flu A/B Diagnostic Test Nuclein has obtained FDA 510(k) clearance for its DASH® Rapid PCR System, allowing 15-minute tests for COVID-19 and influenza. Learn more.

Nuclein Achieves FDA Clearance for Rapid SARS-CoV-2 and Flu A/B Diagnostic Test #United_States #Austin,_Texas #FDA_Clearance #DASH_System #Nuclein

#RandomHashtagOfTheDay for Saturday, December 21 is: #nuclein